OOIR: Observatory of International Research

Papers

(The H4-Index of Atherosclerosis is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	159
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	154
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	118
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	117
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	114
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	109
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	97
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	94
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	90
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	89
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	88
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	84
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	82
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	81
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	81
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	76
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	75
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	74
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	71
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	68
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	68
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	68
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	59
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	58
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	57

ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	56
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	56
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	54
Bivariate relation of vascular health and blood pressure progression during childhood	53
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	53
Rabies vaccine induced microangiopathy	53
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	49
Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?	49
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	46
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	46
Vascular structural changes in diabetes mellitus patients with chronic kidney disease	44
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	43
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	42
Illness perception in patients with familial hypercholesterolemia	42
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	41
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	41
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	41
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	41